IP Verse

Methods For Treating Bone Cancer Pain By Administering A Nerve Growth Factor Antagonistic Antibody - EP2206728

The patent EP2206728 was granted to Regents OF The University OF Minnesota on Oct 10, 2018. The application was originally filed on Apr 7, 2005 under application number EP10151672A. The patent is currently recorded with a legal status of "Revoked".

EP2206728

REGENTS OF THE UNIVERSITY OF MINNESOTA
Application Number
EP10151672A
Filing Date
Apr 7, 2005
Status
Revoked
Nov 4, 2022
Grant Date
Oct 10, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

REGENERON PHARMACEUTICALSDec 14, 2018ADMISSIBLE

Patent Citations (133) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONGB19980009951-
DESCRIPTIONUS20030682331-
DESCRIPTIONUS20030682332-
DESCRIPTIONUS20030682638-
DESCRIPTIONUS20030745775-
DESCRIPTIONUS20040783730-
DESCRIPTIONWO1999GB01441-
DESCRIPTIONWO2003US32083-
DESCRIPTIONWO2003US32089-
DESCRIPTIONWO2003US32113-
DESCRIPTIONWO2003US41252-
DESCRIPTIONWO2004US05162-
DESCRIPTIONEP0345242
DESCRIPTIONEP0519596
DESCRIPTIONEP0524968
DESCRIPTIONGB2200651
DESCRIPTIONUS2001046959
DESCRIPTIONUS2004131615
DESCRIPTIONUS2004237124
DESCRIPTIONUS2004253244
DESCRIPTIONUS3773919
DESCRIPTIONUS4485045
DESCRIPTIONUS4544545
DESCRIPTIONUS4777127
DESCRIPTIONUS4816567
DESCRIPTIONUS5013556
DESCRIPTIONUS5130311
DESCRIPTIONUS5219740
DESCRIPTIONUS5342942
DESCRIPTIONUS5409944
DESCRIPTIONUS5422120
DESCRIPTIONUS5436265
DESCRIPTIONUS5475995
DESCRIPTIONUS5500362
DESCRIPTIONUS5510368
DESCRIPTIONUS5521213
DESCRIPTIONUS5530101
DESCRIPTIONUS5536752
DESCRIPTIONUS5550142
DESCRIPTIONUS5552422
DESCRIPTIONUS5565332
DESCRIPTIONUS5580717
DESCRIPTIONUS5580859
DESCRIPTIONUS5585089
DESCRIPTIONUS5593994
DESCRIPTIONUS5604253
DESCRIPTIONUS5604260
DESCRIPTIONUS5616601
DESCRIPTIONUS5639780
DESCRIPTIONUS5693761
DESCRIPTIONUS5693762
DESCRIPTIONUS5733743
DESCRIPTIONUS5766863
DESCRIPTIONUS5807715
DESCRIPTIONUS5814482
DESCRIPTIONUS5844092
DESCRIPTIONUS5866692
DESCRIPTIONUS5877016
DESCRIPTIONUS5891650
DESCRIPTIONUS5981568
DESCRIPTIONUS5997867
DESCRIPTIONUS6017878
DESCRIPTIONUS6054297
DESCRIPTIONUS6127401
DESCRIPTIONUS6153189
DESCRIPTIONUS6180370
DESCRIPTIONUS6180377
DESCRIPTIONUS6210671
DESCRIPTIONUS6265150
DESCRIPTIONUS6291247
DESCRIPTIONUS6306849
DESCRIPTIONUS6331415
DESCRIPTIONUS6350861
DESCRIPTIONUS6359130
DESCRIPTIONUS6376471
DESCRIPTIONUS6413942
DESCRIPTIONUS6436908
DESCRIPTIONUS6548640
DESCRIPTIONWO0053211
DESCRIPTIONWO0069829
DESCRIPTIONWO0073344
DESCRIPTIONWO0127160
DESCRIPTIONWO0164247
DESCRIPTIONWO0178698
DESCRIPTIONWO0215924
DESCRIPTIONWO0217914
DESCRIPTIONWO0220479
DESCRIPTIONWO2004026329
DESCRIPTIONWO2004032870
DESCRIPTIONWO2004058184
DESCRIPTIONWO2004065560
DESCRIPTIONWO2004073653
DESCRIPTIONWO2005000194
DESCRIPTIONWO2005019266
DESCRIPTIONWO8704462
DESCRIPTIONWO8909225
DESCRIPTIONWO9007936
DESCRIPTIONWO9011092
DESCRIPTIONWO9102805
DESCRIPTIONWO9114445
DESCRIPTIONWO9303769
DESCRIPTIONWO9306213
DESCRIPTIONWO9310218
DESCRIPTIONWO9311230
DESCRIPTIONWO9319191
DESCRIPTIONWO9325234
DESCRIPTIONWO9325698
DESCRIPTIONWO9403622
DESCRIPTIONWO9412649
DESCRIPTIONWO9423697
DESCRIPTIONWO9428938
DESCRIPTIONWO9500655
DESCRIPTIONWO9507994
DESCRIPTIONWO9511984
DESCRIPTIONWO9513796
DESCRIPTIONWO9530763
DESCRIPTIONWO9617072
DESCRIPTIONWO9715593
DESCRIPTIONWO9721732
DESCRIPTIONWO9742338
DESCRIPTIONWO9806048
DESCRIPTIONWO9817278
EXAMINATIONUS5147294
EXAMINATIONWO2004096122
OPPOSITIONUS2004237124
OPPOSITIONUS5147294
OPPOSITIONUS6548062
OPPOSITIONWO0164247
OPPOSITIONWO02096458
OPPOSITIONWO2004096122
SEARCHUS2004131615
SEARCHWO02096458
SEARCHWO2004058184

Non-Patent Literature (NPL) Citations (189) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ABBADIE ET AL., PROC. NATL. ACAD. SCI. U.S.A., (2003), vol. 100, pages 7947 - 52-
DESCRIPTION- ALEY ET AL., NEUROSCIENCE, (1996), vol. 71, pages 1083 - 1090-
DESCRIPTION- AL-LAZIKANI ET AL., J. MOLEC. BIOL., (1997), vol. 273, pages 927 - 948-
DESCRIPTION- ALOE ET AL., ARCH. RHEUM., (1992), vol. 35, pages 351 - 355-
DESCRIPTION- ALOE ET AL., CLIN. EXP. RHEUMATOL., (1992), vol. 10, pages 203 - 204-
DESCRIPTION- ALOE ET AL., INT. J. TISSUE REACTIONS-EXP. CLIN. ASPECTS, (1993), vol. 15, pages 139 - 143-
DESCRIPTION- AMANN ET AL., PAIN, (1996), vol. 64, pages 323 - 329-
DESCRIPTION- ANDREEV ET AL., PAIN, (1995), vol. 63, pages 109 - 115-
DESCRIPTION- APFEL ET AL., MOL. CELL. NEUROSCI., (1996), vol. 7, no. 2, pages 134 - 142-
DESCRIPTION- BISCHOFF ET AL., BLOOD, (1992), vol. 79, pages 2662 - 2669-
DESCRIPTION- BOETTGER ET AL., BRAIN, (2002), vol. 125, pages 252 - 63-
DESCRIPTION- BORSANI ET AL., NUC. ACIDS RES., (1990), vol. 18, page 4020-
DESCRIPTION- BRACCI-LAUDIERO ET AL., NEUROREPORT, (1993), vol. 4, pages 563 - 565-
DESCRIPTION- BRACCI-LAUDIERO ET AL., NEUROSCI. LETT., (1992), vol. 147, pages 9 - 12-
DESCRIPTION- BRAUN ET AL., EUR. J IMMUNOL., (1998), vol. 28, pages 3240 - 3251-
DESCRIPTION- BROWN ET AL., CANCER RES., (1987), vol. 47, pages 3577 - 3583-
DESCRIPTION- BUCHMAN; DAVIES, DEVELOPMENT, (1993), vol. 118, pages 989 - 1001-
DESCRIPTION- BUCK, D. W. ET AL., IN VITRO, (1982), vol. 18, pages 377 - 381-
DESCRIPTION- CARACENI ET AL., J PAIN SYMPTOM MANAGE, (2002), vol. 23, no. 3, pages 239 - 55-
DESCRIPTION- CELL. MOLEC. BIOL., (1993), vol. 13, pages 559 - 568-
DESCRIPTION- CHAO ET AL., SCIENCE, (1986), vol. 232, pages 518 - 521-
DESCRIPTION- CHAPLAN ET AL., J. NEUROSCIENCE METHODS, (1994), vol. 53, pages 55 - 63-
DESCRIPTION- CHOI ET AL., LIFE SCI., (2003), vol. 73, pages 471 - 85-
DESCRIPTION- CHOTHIA ET AL., NATURE, (1989), vol. 342, page 877-
DESCRIPTION- CHUANG ET AL., NATURE, (2001), vol. 411, no. 6840, pages 957 - 62-
DESCRIPTION- CHUN; PATTERSON, DEV. BIOL., (1977), vol. 75, pages 705 - 711-
DESCRIPTION- CLACKSON ET AL., NATURE, (1991), vol. 352, pages 624 - 628-
DESCRIPTION- CLOHISY ET AL., CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, (2003), vol. 415S, pages S279 - S288-
DESCRIPTION- COLQUHOUN ET AL., J. PHARMACOL. EXP. THER., (2004), vol. 310, no. 2, pages 505 - 11-
DESCRIPTION- CONNELLY, HUMAN GENE THERAPY, (1995), vol. 1, page 185-
DESCRIPTION- COREY ET AL., PROSTATE, (2002), vol. 52, pages 20 - 33-
DESCRIPTION- CROWLEY ET AL., CELL, (1994), vol. 76, pages 1001 - 1011-
DESCRIPTION- CURIEL, HUM. GENE THER., (1992), vol. 3, page 147-
DESCRIPTION- DAUGHERTY ET AL., NUCL. ACIDS RES., (1991), vol. 19, pages 2471 - 2476-
DESCRIPTION- DI MARCO ET AL., J. BIOL. CHEM., vol. 268, pages 22838 - 22846-
DESCRIPTION- DYCK ET AL., NEUROLOGY, (1997), vol. 48, pages 501 - 505-
DESCRIPTION- EDOFF ET AL., CELL & TISSUE RESEARCH, (2000), vol. 299, pages 193 - 200-
DESCRIPTION- EIDE ET AL., J NEUROSCI., (1996), vol. 16, page 3123-
DESCRIPTION- EPSTEIN ET AL., PROC. NATL. ACAD SCI. USA, (1985), vol. 82, page 3688-
DESCRIPTION- EUR. J. IMMUNOL., (1999), vol. 29, pages 2613 - 2624-
DESCRIPTION- FALCIMI ET AL., ANN. RHEUM. DIS., (1996), vol. 55, pages 745 - 748-
DESCRIPTION- FAWCETT, D. W., A Textbook of Histology, W.B. SAUNDERS COMPANY, (1986), pages 211 - 213-
DESCRIPTION- FINDEIS ET AL., TRENDS BIOTECHNOL., (1993), vol. 11, page 202-
DESCRIPTION- FJELL ET AL., J. NEUROPHYSIOL., (1999), vol. 81, pages 803 - 810-
DESCRIPTION- FOSTER ET AL., JPATHOL, (2002), vol. 197, no. 2, pages 245 - 55-
DESCRIPTION- GOULD ET AL., BRAIN RES, (2000), vol. 854, no. 1-2, pages 19 - 29-
DESCRIPTION- GREENE; TISCHLER, PROC. NAT. ACAD SCI. USA, (1976), vol. 73, pages 2424 - 2428-
DESCRIPTION- GRIFFITH ET AL., EMBO J., (1993), vol. 12, pages 725 - 734-
DESCRIPTION- HAINS ET AL., NEUROSCI LETT., (2002), vol. 320, no. 3, pages 125 - 8-
DESCRIPTION- HALLIDAY ET AL., NEUROCHEM. RES., (1998), vol. 23, pages 919 - 22-
DESCRIPTION- Handbook of Experimental Immunology-
DESCRIPTION- HASSELSTROM ET AL., PHARMACOLOGY & TOXICOLOGY, (1996), vol. 79, pages 40 - 6-
DESCRIPTION- HONGO ET AL., HYBRIDOMA, (2000), vol. 19, pages 215 - 227-
DESCRIPTION- HONORE ET AL., NAT. MED., (2000), vol. 6, pages 521 - 528-
DESCRIPTION- HONORE ET AL., NAT. MED., (2000), vol. 6, pages 521 - 529-
DESCRIPTION- HONORE ET AL., NAT. MED., (2000), vol. 6, pages 521 - 8-
DESCRIPTION- HONORE ET AL., NATURE MEDICINE, (2000), vol. 6, pages 521 - 528-
DESCRIPTION- HONORE ET AL., NEUROSCIENCE, (2000), vol. 98, pages 585 - 598-
DESCRIPTION- HONORE ET AL., PROG. BRAIN RES., (2000), vol. 129, pages 389 - 397-
DESCRIPTION- HORIGOME ET AL., J. BIOL. CHEM., (1993), vol. 268, pages 14881 - 14887-
DESCRIPTION- HUNT ET AL., NATURE, (1987), vol. 328, pages 632 - 634-
DESCRIPTION- HWANG ET AL., PROC. NATL ACAD. SCI. USA, (1980), vol. 77, page 4030-
DESCRIPTION- IADAROLA ET AL., BRAIN RES., (1988), vol. 455, pages 205 - 212-
DESCRIPTION- JOHNSON, KEVIN S.; CHISWELL, DAVID J., CURRENT OPINION IN STRUCTURAL BIOLOGY, (1993), vol. 3, pages 564 - 571-
DESCRIPTION- JOLLY, CANCER GENE THERAPY, (1994), vol. 1, page 51-
DESCRIPTION- JONES ET AL., NATURE, (1986), vol. 321, pages 522 - 525-
DESCRIPTION- KAPLITT, NATURE GENETICS, (1994), vol. 6, page 148-
DESCRIPTION- KARLSSON, R.; ROOS, H.; FAGERSTAM, L.; PETERSSON, B., METHODS ENZYMOLOGY, (1994), vol. 6, pages 99 - 110-
DESCRIPTION- KASSEL ET AL., CLIN, EXP. ALLERGY, (2001), vol. 31, pages 1432 - 40-
DESCRIPTION- KATZ ET AL., SURG CLIN NORTH AM., (1999), vol. 79, no. 2, pages 231 - 52-
DESCRIPTION- KAWAMOTO ET AL., J. IMMUNOL., (2002), vol. 168, pages 6412 - 6419-
DESCRIPTION- KERR ET AL., NEUROREPORT, (2001), vol. 12, no. 14, pages 3077 - 8-
DESCRIPTION- KIMURA, HUMAN GENE THERAPY, (1994), vol. 5, page 845-
DESCRIPTION- KLEIN ET AL., CELL, (1990), vol. 61, page 647-
DESCRIPTION- KNUSEL ET AL., J. NEUROCHEM., (1992), vol. 59, pages 715 - 722-
DESCRIPTION- KNUSEL ET AL., J. NEUROCHEMISTRY, (1991), vol. 57, pages 955 - 962-
DESCRIPTION- KOHLER, B.; MILSTEIN, C., NATURE, (1975), vol. 256, pages 495 - 497-
DESCRIPTION- KOIZUMI ET AL., J. NEUROSCIENCE, (1988), vol. 8, pages 715 - 721-
DESCRIPTION- LAMBALLE ET AL., EMBO J., (1993), vol. 12, page 3083-
DESCRIPTION- LEON ET AL., PROC. NATL. ACAD. SCI. USA, (1994), vol. 91, pages 3739 - 3743-
DESCRIPTION- LEVI-MONTALCINI, R.; ANGELETTI, P., "Nerve growth factor", PHYSIOL. REV., (1968), vol. 48, pages 534 - 569-
DESCRIPTION- LEWIN ET AL., EUR. J. NEUROSCI., (1994), vol. 6, pages 1903 - 1912-
DESCRIPTION- LEWIN ET AL., EUROPEAN JOURNAL OFNEUROSCIENCE, (1994), vol. 6, pages 1903 - 1912-
DESCRIPTION- LEWIN ET AL., J. NEUROSCI., (1993), vol. 13, pages 2136 - 2148-
DESCRIPTION- LI ET AL., PROC. NATL. ACAD SCI. USA, (1998), vol. 95, page 10884-
DESCRIPTION- LINDHOLM ET AL., EUR. J. NEUROSCI., (1990), vol. 2, pages 795 - 801-
DESCRIPTION- LINDSAY ET AL., NATURE, (1989), vol. 337, pages 362 - 364-
DESCRIPTION- LINDSAY, RM, JNEUROSCI., (1988), vol. 8, no. 7, pages 2394 - 405-
DESCRIPTION- LIU ET AL., J. NEUROSCI, (1997), vol. 17, page 8749-
DESCRIPTION- LOBUGLIO ET AL., PROC. NAT. ACAD. SCI. USA, (1989), vol. 86, pages 4220 - 4224-
DESCRIPTION- LONBERG, N.; D. HUSZAR, INT. REV.IMMUNOL, (1995), vol. 13, page 65-
DESCRIPTION- LUGER ET AL., CANCER RESEARCH, (2001), vol. 61, pages 403 8 - 4047-
DESCRIPTION- LUGER ET AL., CANCER RESEARCH, (2001), vol. 61, pages 4038 - 4047-
DESCRIPTION- LUGER ET AL., PAIN, (2002), vol. 99, pages 397 - 406-
DESCRIPTION- MACH ET AL., NEUROSCIENCE, (2002), vol. 113, pages 155 - 166-
DESCRIPTION- MACH ET AL., NEUROSCIENCE, (2002), vol. 113, pages 155 - 66-
DESCRIPTION- MARK ET AL., J MOL. BIOL., (1991), vol. 222, pages 581 - 597-
DESCRIPTION- MARKS ET AL., BIOLTECHNOL., (1992), vol. 10, pages 779 - 783-
DESCRIPTION- MATSUDA ET AL., PROC. NATL. ACAD. SCI. USA, (1988), vol. 85, pages 6508 - 6512-
DESCRIPTION- MCCAFFERTY ET AL., NATURE, (1990), vol. 348, pages 552 - 553-
DESCRIPTION- MCCARTHY ET AL., NEUROLOGY, (1995), vol. 45, pages 1848 - 1855-
DESCRIPTION- MCCARTHY ET AL., NEUROLOGY, (1995), vol. 45, pages 1848 - 55-
DESCRIPTION- Methods in Enzymology, ACADEMIC PRESS, IND.-
DESCRIPTION- MICHAEL ET AL., J. NEUROSCI, (1997), vol. 17, pages 8476 - 8490-
DESCRIPTION- MILETIC ET AL., NEUROSCI LETT., (2002), vol. 319, no. 3, pages 137 - 40-
DESCRIPTION- MOLANDER C, J COMPO NEUROL., (1987), vol. 260, pages 246 - 255-
DESCRIPTION- MORRISON ET AL., PROC. NAT. ACAD. SCI., (1984), vol. 81, page 6851-
DESCRIPTION- MYERS ET AL., EXP. NEUROL., (1996), vol. 141, pages 94 - 101-
DESCRIPTION- NOGUCHI ET AL., MOLECULAR BRAIN RESEARCH, (1991), vol. 10, pages 227 - 233-
DESCRIPTION- OKRAGLY ET AL., J. UROLOGY, (1991), vol. 161, pages 438 - 441-
DESCRIPTION- OTTEN ET AL., EUR J PHARMACOL., (1984), vol. 106, pages 199 - 201-
DESCRIPTION- OTTEN ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, pages 10059 - 10063-
DESCRIPTION- PEARCE ET AL., J. PHYSIOL., (1986), vol. 372, pages 379 - 393-
DESCRIPTION- PEARCE; THOMPSON, J. PHYSIOL., (1986), vol. 372, pages 379 - 393-
DESCRIPTION- PEETERS ET AL., VACCINE, (2001), vol. 19, page 2756-
DESCRIPTION- PETERSON ET AL., NEUROSCIENCE, (1998), vol. 83, pages 161 - 168-
DESCRIPTION- PETTY ET AL., ANNALS NEUROL., (1994), vol. 36, pages 244 - 246-
DESCRIPTION- PHILIP, MOL. CELL BIOL., (1994), vol. 14, page 2411-
DESCRIPTION- POLLOCK ET AL., J1MMUNOL METHODS, (1999), vol. 231, page 147-
DESCRIPTION- PROC. NATL. ACAD. SCI., (1994), vol. 91, page 1581-
DESCRIPTION- PUIGDELLIVOL-SANCHEZ A ET AL., ANATOMICAL RECORD, (2000), vol. 260, pages 180 - 188-
DESCRIPTION- PUIGDELLIVOL-SANCHEZ A ET AL., NEUROSCI. LETT., (1998), vol. 251, pages 169 - 172-
DESCRIPTION- RAYCHAUDHURI ET AL., ACTA DERM. L'ENEREOL., (1998), vol. 78, pages 84 - 86-
DESCRIPTION- RIECHMANN ET AL., NATURE, (1988), vol. 332, pages 323 - 327-
DESCRIPTION- SABINO ET AL., CANCER RES., (2002), vol. 62, pages 7343 - 7349-
DESCRIPTION- SABINO ET AL., CANCER RES., (2002), vol. 62, pages 7343 - 9-
DESCRIPTION- SABINO ET AL., INTERNATIONAL J. OF CANCER, (2003), vol. 104, pages 550 - 558-
DESCRIPTION- SABINO ET AL., INTERNATIONAL JOURNAL OF CANCER, (2003), vol. 104, pages 550 - 558-
DESCRIPTION- SCHWARTZ ET AL., JPHOTOCHEM, PHOTOBIOL., (2002), vol. 66, pages 195 - 200-
DESCRIPTION- SCHWEI ET AL., J. NERUOSCI., (1999), vol. 19, pages 10886 - 10897-
DESCRIPTION- SCHWEI ET AL., J. NEUROSCI., (1999), vol. 19, pages 10886 - 97-
DESCRIPTION- SCHWEI ET AL., J NEUROSCIENCE, (1999), vol. 19, pages 10886 - 10897-
DESCRIPTION- SEVCIK ET AL., PAIN, (2004), vol. 111, pages 169 - 180-
DESCRIPTION- SEVCIK ET AL., PAIN, (2004), vol. 111, pages 169 - 80-
DESCRIPTION- SHAW ET AL., J IMMUNOL., (1987), vol. 138, pages 4534 - 4538-
DESCRIPTION- SHELTON ET AL., PROC. NATL. ACAD. SCI. U.S.A., (1984), vol. 81, pages 7951 - 5-
DESCRIPTION- SHU; MENDELL, NEUROSCI. LETT., (1999), vol. 274, pages 159 - 162-
DESCRIPTION- SMEYNE ET AL., NATURE, (1994), vol. 368, pages 246 - 249-
DESCRIPTION- SOCIETY FOR NEUROSCIENCE ABSTRACTS, (1998), vol. 24, no. 1-2, page 880-
DESCRIPTION- STEINER ET AL., AM. J. PHYSIOL., (1991), vol. 261, pages F792 - 798-
DESCRIPTION- TAGLIALETELA ET AL., J NEUROCHEM, (1996), vol. 66, no. 5, pages 1826 - 35-
DESCRIPTION- THOMPSON ET AL., PAIN, (1995), vol. 62, pages 219 - 231-
DESCRIPTION- THOMPSON ET AL., PROC NATL ACAD SCI USA, (1999), vol. 96, no. 14, pages 7714 - 8-
DESCRIPTION- TOFARIS ET AL., J NEUROSCI., (2002), vol. 22, pages 6696 - 703-
DESCRIPTION- TORCIA ET AL., CELL., (1996), vol. 85, no. 3, pages 345 - 56-
DESCRIPTION- TORCIA ET AL., CELL, (1996), vol. 85, pages 345 - 356-
DESCRIPTION- TSOULFAS ET AL., NEURON, (1993), vol. 10, page 975-
DESCRIPTION- TSOULFAS ET AL., NEURON, (1993), vol. 10, pages 975 - 990-
DESCRIPTION- TSUJINO ET AL., MOLECULAR & CELLULAR NEUROSCIENCES, (2000), vol. 15, pages 170 - 82-
DESCRIPTION- UEYAMA ET AL., J. HYPERTENS., (1993), vol. 11, pages 1061 - 1065-
DESCRIPTION- ULLRICH ET AL., NATURE, (1983), vol. 303, pages 821 - 825-
DESCRIPTION- URFER ET AL., BIOCHEM., (1997), vol. 36, pages 4775 - 478 1-
DESCRIPTION- VALENZUELA ET AL., NEURON, (1993), vol. 10, page 963-
DESCRIPTION- VANDERAH ET AL., PAIN, (2001), vol. 92, pages 5 - 9-
DESCRIPTION- VERHOEYEN ET AL., SCIENCE, (1988), vol. 239, pages 1534 - 1536-
DESCRIPTION- WATERHOUSE ET AL., NUCL. ACIDS RES., (1993), vol. 21, pages 2265 - 2266-
DESCRIPTION- WINTER ET AL., ANNU. REV. IMMUNOL., (1994), vol. 12, pages 433 - 455-
DESCRIPTION- WINTER ET AL., NATURE, (1991), vol. 349, pages 293 - 299-
DESCRIPTION- WOOLF ET AL., J NEUROSCI., (1996), vol. 16, pages 2716 - 2723-
DESCRIPTION- WOOLF ET AL., J. NEUROSCI., (1996), vol. 16, pages 2716 - 2723-
DESCRIPTION- WOOLF ET AL., J. NEUROSCI., (2001), vol. 21, no. 3, pages 1047 - 55-
DESCRIPTION- WU ET AL., J. BIOL. CHEM., (1988), vol. 263, page 621-
DESCRIPTION- WU ET AL., J. BIOL. CHEM., (1991), vol. 266, page 338-
DESCRIPTION- WU ET AL., J. BIOL. CHEM., (1994), vol. 269, page 542-
DESCRIPTION- WU, J. BIOL. CHEM., (1989), vol. 264, page 16985-
DESCRIPTION- YAN ET AL., CLIN. SCI. (LOND), (1991), vol. 80, pages 565 - 569-
DESCRIPTION- ZENKE ET AL., PROC. NATL. ACAD. SCI. USA, (1990), vol. 87, page 3655-
OPPOSITION- GOLTZMAN, "Mechanisms of the development of osteoblastic metastases", CANCER Suppl., (19970000), vol. 80, no. 8, pages 1581 - 1587, XP008109991-
OPPOSITION- JONGEN et al., "NEUROTROPHIC FACTORS AND CANCER PAIN: THE EXPRESSION OF NGF, GDNF AND BDNF BY THE MURINE OSTEOLYTIC SARCOMA CELL LINE 2472 IN VITRO AND IN VIVO AND THEIR POTENTIAL INVOLVEMENT IN BONE CANCER PAIN", Abstracts of the Annual Meeting of the Society for Neuroscience, (20020000), XP009060864-
OPPOSITION- RO et al., "Effect of NGF and anti-NGF on neuropathic pain in rats following chronic constriction injury of the sciatic nerve", Pain, (19990000), vol. 79, pages 265 - 274, XP027336158-
OPPOSITION- Roodman, G.D., (20180723), URL: https://www.uptodate.com/contents/mechanisms-of-bone-metastases, XP055542394-
OPPOSITION- ZHU et al., "NERVE GROWTH FACTOR EXPRESSION CORRELATES WITH PERINEURAL INVASION AND PAIN IN HUMAN PANCREATIC CANCER", Journal of Clinical Oncology, (19990800), vol. 17, no. 8, pages 2419 - 2428, XP001015680-
OPPOSITION- WALCH et al., "Role of neurotrophins and neurotrophin receptors in the in vitro invasion and heparanase production of human prostate cancer cells", Clinical and Experimental Metastasis, (19990000), vol. 17, pages 307 - 314, XP055542219
OPPOSITION- MCMAHON et al., "The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule", Nature Medicine, (19950800), vol. 1, no. 8, pages 774 - 780, XP009073417
OPPOSITION- LOGOTHETIS et al., "Osteoblasts in prostate cancer metastasis to bone", Nature Reviews, Cancer, (20050100), vol. 5, pages 21 - 28, XP055542199
OPPOSITION- MANTYH et al., "MOLECULAR MECHANISMS OF CANCER PAIN", Nature Reviews, Cancer, (20020300), vol. 2, pages 201 - 209, XP009060895
OPPOSITION- ROODMAN, "Mechanisms of Bone Metastasis", The New England Journal of Medicine, (20040000), vol. 350, pages 1655 - 1664, XP055542390
OPPOSITION- HONGO et al., "ANTIBODY BINDING REGIONS ON HUMAN NERVE GROWTH FACTOR IDENTIFIED BY HOMOLOG- AND ALANINE-SCANNING MUTAGENESIS", Hybridoma, (20000000), vol. 19, no. 3, pages 215 - 227, XP002951932
OPPOSITION- BATAILLE et al., "Osteoblast stimulation in multiple myeloma lacking lytic bone lesions", British Journal of Haematology, (19900000), vol. 76, pages 484 - 487, XP055542209
OPPOSITION- CAIN et al., "Response Properties of Mechanoreceptors and Nociceptors in Mouse Glabrous Skin: An In Vivo Study", J. Neurophysiol., (20010000), vol. 85, pages 1561 - 1574, XP055542170
OPPOSITION- HALVORSON et al., "A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone", Cancer Res., (20051015), vol. 65, no. 20, pages 9426 - 9435, XP002365572
OPPOSITION- GHOBRIAL, "Myeloma as a model for the process of metastasis: implications for therapy", Blood, (20120000), vol. 120, no. 1, pages 20 - 30, XP055476873
OPPOSITION- GUISE et al., "Cancer and Bone", Endocrine Reviews, (19980000), vol. 19, no. 1, pages 18 - 54, XP055542376
OPPOSITION- SCHWEI et al., "Neurochemical and Cellular Reorganization of the Spinal Cord in a Murine Model of Bone Cancer Pain", J. Neuroscience, (19990000), vol. 19, no. 24, pages 10866 - 10897, XP055542152
SEARCH- JONGEN J L M ET AL, "NEUROTROPHIC FACTORS AND CANCER PAIN: THE EXPRESSION OF NGF, GDNF AND BDNF BY THE MURINE OSTEOLYTIC SARCOMA CELL LINE 2472 in vitro AND in vivo AND THEIR POTENTIAL INVOLVEMENT IN BONE CANCER PAIN.", SOCIETY FOR NEUROSCIENCE ABSTRACT VIEWER AND ITINERARY PLANNER, & 32ND ANNUAL MEETING OF THE SOCIETY FOR NEUROSCIENCE; ORLANDO, FLORIDA, USA; NOVEMBER 02-07, 2002, (2002), vol. 2002, page HTTP://SF, XP009060864 [Y] 1-14 * abstract *-
SEARCH- SHELTON D L ET AL, "Neurotrophins and neurotrophin antagonists as potential therapeutics", RESTORATIVE NEUROLOGY AND NEUROSCIENCE 1995 IRELAND, (1995), vol. 8, no. 1-2, ISSN 0922-6028, pages 99 - 100, XP009060880 [A] 1-14 * the whole document *-
SEARCH- SEVCIK M A ET AL, "Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization", PAIN, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (200505), vol. 115, no. 1-2, ISSN 0304-3959, pages 128 - 141, XP004844690 [T] * the whole document *
SEARCH- HONGO J-A S ET AL, "ANTIBODY BINDING REGIONS ON HUMAN NERVE GROWTH FACTOR IDENTIFIED BY HOMOLOG- AND ALANINE-SCANNING MUTAGENESIS", HYBRIDOMA, LIEBERT, NEW YORK, NY, US, (2000), vol. 19, no. 3, ISSN 0272-457X, pages 215 - 227, XP002951932 [AD] 1-14 * the whole document *
SEARCH- HALVORSON KYLE G ET AL, "A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone", CANCER RESEARCH, (200510), vol. 65, no. 20, ISSN 0008-5472, pages 9426 - 9435, XP002365572 [T] * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents